AVIR

NASDAQ · Pharmaceuticals

Atea Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.25

+0.26 (+5.21%)

As of Aug 8, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +777.1% upside

Low Target $31.54

Average Target $46.05

High Target $64.23

Current Price $5.25

Current
$5.25

Target
$46.05

$31.54 $46.05 avg $64.23

Scenario Analysis

Bear Case

$31.54

500.8%

Low target

Base Case

$46.05

+777.1%

Avg target

Bull Case

$64.23

+1,123.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$6.45

-18.6% from high

52-Week Low

$2.78

+88.8% from low

Target vs 52W High

$46.05

+614.0% vs high

Next Earnings Report

Aug 12, 2026 · After Market Close

until earnings

EPS Est: $-0.57

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%